US 11453710
Activatable interleukin 12 polypeptides and methods of use thereof
granted A61KA61K2039/585A61K38/00
Quick answer
US patent 11453710 (Activatable interleukin 12 polypeptides and methods of use thereof) held by Werewolf Therapeutics, Inc. expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Werewolf Therapeutics, Inc.
- Grant date
- Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/585, A61K38/00